Listings on the PBS for Aboriginal and Torres Strait Islander People

A list of Pharmaceutical Benefits Schedule (PBS) items that are limited for prescription to Aboriginal and Torres Strait Islander people. Benefits are based on the 1 January 2017 Pharmaceutical Benefits Schedule (PBS).

Page last updated: 16 January 2017

PDF version: PBS items that are limited for prescription to Aboriginal and Torres Strait Islander people (PDF 493 KB)

Listed PBS items

Authority Required (STREAMLINED)

  • 6434: Treatment of a fungal or yeast infection in an Aboriginal or Torres Strait Islander person.
Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
9024YKetoconazole
2% (20mg/g) cream, 30g
Nizoral 2% Cream Johnson & Johnson
1
2
9025BKetoconazole 1%
(10mg/g) shampoo, 100mL
Nizoral 1%Johnson & Johnson
1
1
1574WKetoconazole 2%
(20mg/g) shampoo, 60mL
Nizoral 2%Johnson & Johnson
1
1
9027D Miconazole nitrate
2% (20mg/g) cream, 30g
DaktarinJohnson & Johnson
1
2
9028E Miconazole nitrate
2% (20mg/g) cream, 70g
DaktarinJohnson & Johnson
1
1
9029F Miconazole nitrate
2% (20mg/g) dusting powder, 30g
DaktarinJohnson & Johnson
1
2
9031H Miconazole
2% solution, 30mL
Daktarin
Tincture
Johnson & Johnson
1
2
1698J Nystatin
100,000 IU/g, cream 15g
MycostatinFawns and McAllan
2
3
9160D Terbinafine hydrochloride
1% cream, 15g
Lamisil Novartis
2
3
Top of page

Authority Required (STREAMLINED)

  • 5139: Prophylaxis of thiamine deficiency in an Aboriginal or Torres Strait Islander person.
Item codeName and Manner of administrationBrand Name ManufacturerMax QuantityNo. of Repeats
1070H Thiamine hydrochloride
100mg tablet
BetavitPetrus Pharmaceuticals
100
2

Authority Required

  • 5506 Hypomagnesaemia or 5466 chronic renal disease in Aboriginal or Torres Strait Islander person.
Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
5146W Magnesium Aspartate Dihydrate
500mg (equivalent to 37.4 mg of magnesium) tablet
Mag-SupPetrus Pharmaceuticals
50
5
MagMin (PBS)Blackmores
50
5

Authority Required (STREAMLINED)

  • 5817: Treatment of whipworm infestation in an Aboriginal or Torres Strait Islander person.
Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
9047EAlbendazole
200 mg tablet, chewable
Zentel Aspen Pharmacare
6
0
Top of page

Authority Required (STREAMLINED)

  • Treatment of chronic suppurative otitis media in an Aboriginal or Torres Strait Islander person aged 1 month or older.
Item code
Name Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
2480MCiprofloxacin
0.3% ear drops, 5 mL
CiloxanAlcon Laboratories
1
1

Authority Required

  • Treatment of a dermatophyte infection in an Aboriginal or Torres Strait Islander person where topical treatment has failed.
Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
2285GTerbinafine
250 mg tablet, 42
GenRx TerbinafineApotex
42
0
2285GTerbinafine
250 mg tablet, 42
LamisilNovartis
42
0
2285GTerbinafine
250 mg tablet, 42
Sebifin 250Ranbaxy
42
0
2285GTerbinafine
250 mg tablet, 42
TamsilArrow Pharma
42
0
2285GTerbinafine
250 mg tablet, 42
Terbinafine ANAmneal Pharmaceuticals
42
0
2285GTerbinafine
250 mg tablet, 42
Terbinafine GHGeneric Health
42
0
2285GTerbinafine
250 mg tablet, 42
Terbinafine SandozSandoz
42
0
2285GTerbinafine
250 mg tablet, 42
Terbinafine-DRLADr Reddy's Laboratories
42
0
2285GTerbinafine
250 mg tablet, 42
TinasilAlphapharm
42
0
Top of page
  • Nicotine dependence

Clinical criteria: The treatment must be the sole PBS-subsidised therapy for this condition.

Population criteria: Patient must be an Aboriginal or Torres Strait Islander person.

Note: Only two courses of PBS-subsidised nicotine replacement therapy may be prescribed per 12-month period. Benefit is improved if used in conjunction with a comprehensive support and counselling program.
Note: No increase in the maximum quantity or number of units may be authorised.
Note: No increase in the maximum number of repeats may be authorised.

Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
5465PNicotine
21 mg/24 hours patch
Nicabate PGlaxoSmithKline
28
2 per yr
5571FNicotine
21 mg/24 hours patch
Nicotinell Step 1Orion Laboratories
28
2 per yr
10076HNicotine
25 mg/16 hours patch
Nicorette 16hr InvispatchJohnson and Johnson
28
2 per yr

Authority Required (STREAMLINED)

  • 6647 Nasal colonisation with Staphylococcus aureus in an Aboriginal or Torres Strait Islander person.

Note: No applications for increased maximum quantities and/or repeats will be authorised.

Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
9440WMupirocin
2% (20 mg/g) ointment, 3 g
BactrobanGlaxoSmithKline
1
0

For treatment of constipation in an Aboriginal or Torres Strait Islander person who:

  • is paraplegic or quadriplegic or has severe neurogenic impairment of bowel function
  • is receiving palliative care
  • is receiving long term nursing care on account of age, infirmity or other condition in a hospital, nursing home, or residential facility, or
  • is receiving long term nursing care and in respect of whom a Carer Allowance is payable as a disabled adult, or
  • has terminal malignant neoplasia, anorectal congenital abnormalities or Megacolon.
Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
1258FBisacodyl
10 mg suppository
Petrus Bisacodyl SuppositoriesPetrus
3
4
1260HBisacodyl
10 mg suppository
Petrus Bisacodyl Suppositories
Petrus
3
5
DulcolaxBoehringer Ingelheim
3
5
Top of page

The following items are for the treatment of a patient identifying as an Aboriginal or Torres Strait Islander person.

Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
1010E or 5018D (Dental)Aspirin
300 mg tablet, effervescent
SolprinReckitt Benckiser
96
1
(No repeats for Dental)
8202QAspirin
100 mg tablet
Spren 100Aspen Pharma
112
1
3196FSodium chloride, potassium chloride, glucose monohydrate and citrate
Oral liquid powder, 10 x 4.9 g sachets
Repalyte new formulationSanofi-aventis
1
0
Restore O.R.S.Amneal
1
0
1437PFolic acid
5 mg tablet, for malabsorption states only
Megafol 5Alphapharm
200
1
2958QFolic acid
500 mcg tablet
Foltabs 500
Petrus
200
0
Megafol 0.5Alphapharm
200
0
3106LGlucose and ketone indicator urine
50 diagnostic strips
Keto-Diabur-Test 5000Roche Diagnostics
2
2
3107MGlucose and ketone indicator urine
50 diagnostic strips
Keto-DiastixBayer
2
2
3104JGlucose indicator urine
50 diagnostic strips
DiastixBayer
2
2
1746X or 5196L (Dental)Paracetamol
500 mg tablets
Note: No repeats for dental.
APO-ParacetamolApotex
100
1
FebridolAmneal
100
1
Generic Health
Generic Health
100
1
PanamaxSanofi-aventis
100
1
Paracetamol (Sandoz)Sandoz
100
1
ParalginFawns and McAllan
100
1
ParapaneAlphapharm
100
1
1747YParacetamol
120 mg / 5 mL oral liquid, 100 mL
PanamaxSanofi-aventis
1
2
1770EParacetamol
240 mg / 5 mL oral liquid, 200 mL
Panamax 240 ElixirSanofi-aventis
1
2
3348FParacetamol (Dental)
120 mg / 5 mL oral liquid, 100 mL
PanamaxSanofi-aventis
1
0
3349GParacetamol (Dental)
240 mg / 5 mL oral liquid, 200 mL
Panamax 240 ElixirSanofi-aventis
1
0
Top of page

For the treatment of chronic arthropathies.

Population criteria: Patient must identify as an Aboriginal or Torres Strait Islander person.

Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
8784H or 5224Y (Dental)Paracetamol
500 mg tablet
Note: No repeats for dental.
APO-ParacetamolApotex
300
4
FebridolAmneal
300
4
Generic HealthGeneric Health
300
4
PanamaxSanofi-aventis
300
4
Paracetamol (Sandoz)Sandoz
300
4
ParalginFawns and McAllan
300
4
ParapaneAlphapharm
300
4

For the treatment of persistent pain associated with osteoarthritis in an Aboriginal or Torres Strait Islander person.

Note: Pharmaceutical benefits that have the form paracetamol 665mg tablet: modified release, 96 and pharmaceutical benefits that have the form paracetamol 665mg tablet: modified release, 192 are equivalent for the purposes of substitution.

Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
8814XParacetamol
665 mg tablet, modified release, 96
Osteomol 665 ParacetamolPharmacor
192
5
10797GParacetamol
665mg tablet, modified release, 192
Osteomol 665 ParacetamolPharmacor
192
5

For the treatment of pernicious anaemia, proven vitamin B12 deficiencies other than pernicious anaemia in an Aboriginal or Torres Strait Islander person, or for prophylaxis of anaemias associated with vitamin B12 deficiency for a person who has had a gastrectomy.

Note: One injection of hydroxocobalamin 1 mg every three months provides appropriate maintenance therapy in vitamin B12 deficiencies.
Note: Pharmaceutical benefits that have the form hydroxocobalamin injection 1mg (as acetate) in 1mL and pharmaceutical benefits that have the form hydroxocobalamin injection 1mg (as chloride) in 1 mL are equivalent for the purposes of substitution.

Item code
Name and Manner of administration
Brand Name
Manufacturer
Max Quantity
No. of Repeats
2162THydroxocobalamin
1 mg / mL injection, 3 x 1 mL ampoules
(Vita-B12)Mercury Pharma
3
0
9048FHydroxocobalamin
1 mg / mL injection, 3 x 1 mL ampoules
(Neo-B12)Hospira
3
0

All information in this publication is correct as of January 2017

The Pharmaceutical Benefits Schedule provided more information regarding medicines subsidised by the Australian Government as well as information for consumers, carers, health professionals and the pharmaceutical industry. The PBS is part of Australia's broader National Medicines Policy (NMP)

If you are unable to download the PDF please email IHD 19.2 enquiries mailbox

Top of page